Charles River Laboratorie (CRL.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec12

Bayesian Capital Management Acquired Charles River Laboratories International's Stock in Q2

08:25

Dec4

New York State Common Retirement Fund Reduces Holdings in Charles River Laboratories International

11:44

Dec1

Charles River Laboratories to Attend Evercore's 8th Annual Healthcare Conference

13:01

Nov29

Redburn Atlantic Raises Charles River Laboratories' Stock Rating to Neutral

10:07

Nov25

Horizon Kinetics Reduces Holdings in Charles River Laboratories

12:36

Nov17

SEC Ends Investigation of Charles River Laboratories Without Enforcement Action

13:07

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.005 B, Net Income 54.42 M, EPS 1.1

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.032 B, Net Income 52.33 M, EPS 1.06

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 984.17 M, Net Income 25.47 M, EPS 0.5

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change